drugset

drugset / Trial / NCT00458185

Study Evaluating Etanercept in Patients With Ankylosing Spondylitis

NCT00458185 ↗

Phase 4 Completed 40 enrolled Wyeth is now a wholly owned subsidiary of Pfizer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study will assess the efficacy of etanercept for the treatment of Ankylosing Spondylitis (AS).

Timeline

Start: 2006-08
Primary completion: —
Completion: 2007-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Etanercept	Protein / enzyme biologic	—	—

Indications